Abstract: The invention provides a dinucleoside polyphosphate analogue, or a pharmaceutically acceptable salt thereof, for use in the inhibition (or down-regulation) of a pain, via a transducing ATP-gated P2X3 receptor, often by means of high-affinity desensitisation (HAD) mechanism.
Type:
Application
Filed:
May 24, 2013
Publication date:
April 30, 2015
Applicant:
GlobalAcornLtd.
Inventors:
Andrew David Miller, Natalya Lozovaya, Nail Burnashev, Rashid Giniatullin